Table 2 Patient characteristics: lung diseases
From: Use of a sealant to prevent prolonged air leaks after lung resection: a prospective randomized study
Diagnosis | Control group n (%) | Sealant group n (%) |
|---|---|---|
Total n, (%) | 105 (100.0) | 111 (100.0) |
Malignant disease | 75 (71.5) | 82 (73.9) |
Primary lung neoplasm | 52 (49.5) | 47 (42.3) |
Adenocarcinoma | 33 (31.4) | 18 (16.2) |
Epidermoid | 18 (17.1) | 16 (14.4) |
Bronchoalveolar | 10 (9.52) | 5 (4.50) |
Poorly differentiated | 5 (4.76) | 3 (2.70) |
Adenosquamous | 3 (2.86) | 1 (0.90) |
Neuroendocrine | 3 (2.86) | 1 (0.90) |
Typical carcinoid | 3 (2.86) | 2 (1.80) |
Atypical carcinoid | 0 (0.0) | 1 (0.90) |
Metastasis | 23 (21.9) | 35 (31.5) |
Kidney | 2 (1.90) | 4 (3.60) |
Ovarian | 1 (0.95) | 7 (6.31) |
Skin | 1 (0.95) | 3 (2.70) |
Salivary ducts | 2 (1.90) | 1 (0.90) |
Prostatic | 2 (1.90) | 3 (2.70) |
Breast | 14 (13.3) | 11 (9.91) |
Colorectal | 2 (1.90) | 6 (5.40) |
Benign disease | 30 (28.6) | 29 (26.1) |
Flogistic | 23 (21.9) | 23 (20.7) |
Disonthogenetic | 5 (4.76) | 5 (4.50) |
Hydatid cyst | 2 (1.90) | 1 (0.90) |